Skip to content

FUSE MEDICAL, INC.: 10-Q filed 2019-11-14

What FUSE MEDICAL, INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 45 published measures, 130 facts as tagged in accession 0001564590-19-043448.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001564590-19-043448 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-3018,156,574USD
At 2018-12-3122,172,851USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-3020,919,855USD
At 2018-12-3120,706,167USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30-2,763,281USD
At 2019-06-301,312,644USD
At 2019-03-311,200,093USD
At 2018-12-311,466,684USD
At 2018-09-30-5,007,404USD
At 2018-06-30-8,796,947USD
At 2018-03-31-8,578,390USD
At 2017-12-31-7,981,509USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-301,031,270USD
At 2018-12-31844,314USD
At 2018-09-30594,880USD
At 2017-12-31804,715USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-4,064,342USD92
2019-01-01 to 2019-09-30-4,717,489USD273
2019-04-01 to 2019-06-30-142,149USD91
2019-01-01 to 2019-03-31-510,998USD90
2018-07-01 to 2018-09-30277,182USD92
2018-01-01 to 2018-09-30-2,073,082USD273
2018-04-01 to 2018-06-30-1,615,297USD91
2018-01-01 to 2018-03-31-734,967USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-88,097USD273
2018-01-01 to 2018-09-302,938,508USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-3035,984USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-07-01 to 2019-09-305,716,344USD92
2019-01-01 to 2019-09-3015,562,928USD273
2018-07-01 to 2018-09-306,784,304USD92
2018-01-01 to 2018-09-3018,506,810USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-30275,053USD273
2018-01-01 to 2018-09-30-3,049,262USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-99,081USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-3,965,696USD
At 2018-12-31751,793USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-07-01 to 2019-09-3070,221,566shares92
2019-01-01 to 2019-09-3070,221,566shares273
2018-07-01 to 2018-09-3068,658,304shares92
2018-01-01 to 2018-09-3066,816,698shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-0.06USD/shares92
2019-01-01 to 2019-09-30-0.07USD/shares273
2018-07-01 to 2018-09-300USD/shares92
2018-01-01 to 2018-09-30-0.03USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-07-01 to 2019-09-30926,517USD92
2019-01-01 to 2019-09-30771,582USD273
2018-07-01 to 2018-09-3090,985USD92
2018-01-01 to 2018-09-30-505,742USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-3027,123USD
At 2018-12-3142,974USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-09-30487,524USD273
2018-01-01 to 2018-09-30696,843USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-3,102,925USD92
2019-01-01 to 2019-09-30-3,857,545USD273
2018-07-01 to 2018-09-30394,087USD92
2018-01-01 to 2018-09-30-2,476,989USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-3013,997,387USD
At 2018-12-3117,175,755USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-3034,900USD92
2019-01-01 to 2019-09-3088,362USD273
2018-07-01 to 2018-09-3025,920USD92
2018-01-01 to 2018-09-30101,835USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-307,338,326USD
At 2018-12-317,124,638USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-302,526,096USD
At 2018-12-312,712,919USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2019-09-302,905,089USD
At 2018-12-312,905,089USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-09-304,759,131USD
At 2018-12-315,225,999USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-304,031,330USD92
2019-01-01 to 2019-09-3010,433,277USD273
2018-07-01 to 2018-09-303,342,844USD92
2018-01-01 to 2018-09-3011,042,528USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-308,189,621USD
At 2018-12-3111,075,889USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30928,405USD92
2019-01-01 to 2019-09-306,575,732USD273
2018-07-01 to 2018-09-303,736,931USD92
2018-01-01 to 2018-09-308,565,539USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-07-01 to 2019-09-304,787,939USD92
2019-01-01 to 2019-09-308,987,196USD273
2018-07-01 to 2018-09-303,047,373USD92
2018-01-01 to 2018-09-309,941,271USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,263,964USD92
2019-01-01 to 2019-09-306,604,066USD273
2018-07-01 to 2018-09-301,932,991USD92
2018-01-01 to 2018-09-306,432,798USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3070,221,566shares
At 2018-12-3170,221,566shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2019-09-3063,371USD
At 2018-12-3168,800USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2019-09-3036,248USD
At 2018-12-3125,826USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2019-09-301,226,975USD
At 2018-12-311,288,040USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-09-302,909,729USD
At 2018-12-312,784,271USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-3017,365USD
At 2018-12-3129,553USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-4,717,489USD273
2018-01-01 to 2018-09-30-2,073,082USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-07-01 to 2019-09-305,241USD92
2019-01-01 to 2019-09-3015,851USD273
2018-07-01 to 2018-09-304,829USD92
2018-01-01 to 2018-09-3010,650USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-07-01 to 2019-09-3025,596USD92
2019-01-01 to 2019-09-3076,916USD273
2018-07-01 to 2018-09-304,829USD92
2018-01-01 to 2018-09-3010,650USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-07-01 to 2019-09-3020,355USD92
2019-01-01 to 2019-09-3061,065USD273
2018-07-01 to 2018-09-300USD92
2018-01-01 to 2018-09-300USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-34,900USD92
2019-01-01 to 2019-09-30-88,362USD273
2018-07-01 to 2018-09-30-25,920USD92
2018-01-01 to 2018-09-30-101,835USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2019-01-01 to 2019-09-3010,589USD273
2018-01-01 to 2018-09-3032,121USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2019-01-01 to 2019-09-30760,993USD273
2018-01-01 to 2018-09-30-533,639USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-3069,257USD273
2018-01-01 to 2018-09-3084,872USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30612,769USD273
2018-01-01 to 2018-09-30-2,598,303USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-181,656USD273
2018-01-01 to 2018-09-30-1,201,714USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-186,823USD273
2018-01-01 to 2018-09-30-440,540USD273

Inspect the source

Entity
FUSE MEDICAL, INC. / CIK 0000319016
Captured
2026-09-19T11:14:02.031Z
SEC response SHA-256
13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))